Methods for improved sensitivity of lateral flow tests

In collaboration with Axxin Ltd and The University of Melbourne, the Anderson Diagnostics lab will integrate innovative techniques in nanotechnology to the development of robust and sensitive rapid assays, addressing targets for eradication of viral hepatitis and malaria that are beyond the sensitivity of current diagnostic technologies.


  • Chris Woodrow (PhD student)
  • Caroline Heidrich Siebert (PhD student)
  • Bill Hopper, Axxin Ltd
  • Paul Mulvaney, University of Melbourne
  • Professor Sharon Lewin, Doherty Institute

Health Issues

Contact Details

For any general enquiries relating to this project, please contact:

Burnet Institute

[email protected]